510(k) K202517
K202517 is an FDA 510(k) premarket notification submitted by Cytrellis Biosystems, Inc. for the device "Cytrellis Dermal Micro-Coring System". The FDA issued a decision of Substantially Equivalent on July 9, 2021. The device falls under product code QAI (Powered Microneedle Device), a Class II device regulated under 21 CFR 878.4430. Cytrellis Biosystems, Inc. has at least 1 other 510(k) clearance on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- July 9, 2021
- Date Received
- September 1, 2020
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Powered Microneedle Device
- Device Class
- Class II
- Regulation Number
- 878.4430
- Review Panel
- SU
- Submission Type
A powered microneedle device is a device using one or more needles to mechanically puncture and injure skin tissue for aesthetic use.